A personal account of one young woman who suffered tardive dyskinesia after being treated for nausea. Also offers links to support groups.

Article in the American Journal of Psychiatry reports on a study that found that olanzapine was less likely to cause dyskinesia than haloperidol.

Argues against the routine use of neuroleptic medications to treat psychiatric disorders because of the high risk of tardive dyskinesia.

Offers details about clinical trials for tardive dyskinesia, along with profiles of research centers that specialize in the disorder.

National Alliance for the Mentally Ill site describes how anti-psychotic medications are cause dyskinesia and the latest avenues of research.

National Organization for Rare Disorders presents an overview of the underlying causes of this neurological condition and lists support groups.

Describes new approaches to pharmacological management of this movement disorder, including the use of the medication buspirone.

Japan's National Institute of Health Sciences summarizes research into the use of calcium-channel blockers to treat tardive dyskinesia.

Presents results from a double-blind study that found that Vitamin E therapy was effective in controlling the symptoms of tardive dyskinesia.